L. R. Kelland

Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells.

C. O'Neill, L. Kèlland, L. Hunakova, 1999, Chemico-biological interactions.

Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.

L. Kèlland, P. Rogers, S. Sharp, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.

L. Kèlland, J. Roberts, G. Abel, 1992, Cancer research.

BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin.

N. Farrell, F. Zunino, R. Supino, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.

L. Kèlland, M. Valenti, B. Murrer, 1993, Cancer research.

Comparison of cellular accumulation and cytotoxicity of cisplatin with that of tetraplatin and amminedibutyratodichloro(cyclohexylamine)platinum(IV) (JM221) in human ovarian carcinoma cell lines.

L. Kèlland, B. Murrer, G. Abel, 1992, Cancer research.

The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.

S. Sidhar, L. Kelland, G. Abel, 1991, British Journal of Cancer.

Mechanisms of acquired resistance to the orally active platinum-based anticancer drug bis-acetato-ammine-dichloro-cyclohexylamine platinum (i.v.) (JM216) in two human ovarian carcinoma cell lines.

K. Mellish, L. R. Kelland, 1994, Cancer research.

Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes.

L. Kèlland, G. Abel, P. Mistry, 1992, British Journal of Cancer.